ArticleTheranostics2022

HER2-targeted dual radiotracer approach with clinical potential for noninvasive imaging of trastuzumab-resistance caused by epitope masking.

Liqiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.